Neurol 1(8):544–553. https://doi.org/10.
1002/acn3.83
4. Neiman M, Hedberg JJ, Do ¨nnes PR, SchuppeKoistinen I, Hanschke S, Schindler R, Uhle ´n M,
Schwenk JM, Nilsson P (2011) Plasma profiling
reveals human fibulin-1 as candidate marker for
renal impairment. J Proteome Res 10
(11):4925–4934. https://doi.org/10.1021/
pr200286c
5. Todd DJ, Knowlton N, Amato M, Frank MB,
Schur PH, Izmailova ES, Roubenoff R, Shadick
NA, Weinblatt ME, Centola M, Lee DM (2011)
Erroneous augmentation of multiplex assay
measurements in patients with rheumatoid
arthritis due to heterophilic binding by serum
rheumatoid factor. Arthritis Rheum 63
(4):894–903.
https://doi.org/10.1002/art.
30213
6. Bartels EM, Ribel-Madsen S (2013) Cytokine
measurements and possible interference from
heterophilic antibodies--problems and solutions
experienced with rheumatoid factor. Methods
61(1):18–22.
https://doi.org/10.1016/j.
ymeth.2012.12.015
7. Schwenk JM, Igel U, Neiman M, Langen H,
Becker C, Bjartell A, Ponten F, Wiklund F,
Gro ¨nberg H, Nilsson P, Uhlen M (2010)
Toward next generation plasma profiling via
heat-induced epitope retrieval and array-based
assays.
Mol
Cell
Proteomics
9
(11):2497–2507. https://doi.org/10.1074/
mcp.M110.001560
Minimizing Rheumatoid Factor Interference
151